Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Nebivolol Hydrochloride; Valsartan Patent Expiration

Nebivolol Hydrochloride; Valsartan is Used for managing high blood pressure. It was first introduced by Abbvie Inc in its drug Byvalson on Jun 3, 2016. 2 different companies have introduced drugs containing Nebivolol Hydrochloride; Valsartan.


Nebivolol Hydrochloride; Valsartan Patents

Given below is the list of patents protecting Nebivolol Hydrochloride; Valsartan, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Byvalson US7838552 Compositions comprising nebivolol Oct 04, 2027 Abbvie
Byvalson US7803838 Compositions comprising nebivolol Aug 29, 2026 Abbvie



Nebivolol Hydrochloride; Valsartan's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Nebivolol Hydrochloride; Valsartan Generic API Manufacturers

Only one generic application has been filed for Nebivolol Hydrochloride; Valsartan.

Given below is the list of companies who have filed for Nebivolol Hydrochloride; Valsartan generic, along with the locations of their manufacturing plants worldwide.


1. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 1 generic for Nebivolol Hydrochloride; Valsartan. This eq 5mg base;80mg version comes by the name VYDUO. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 80MG

tablet Prescription ORAL N/A Sep 19, 2022